ArticleThe open cardiovascular medicine journal2014
Beta-blockers Associated with a Mortality Benefit in Patients with Systolic Dysfunction and Elevated Serum Bilirubin.
Christopher Labos et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.